Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255050, C514S256000, C514S293000, C544S105000, C544S333000, C544S405000, C544S060000, C544S126000, C544S361000, C544S250000, C546S081000, C540S575000
Reexamination Certificate
active
06916809
ABSTRACT:
Compounds having the formula (I),wherein R3is selected from H, OH and NH2; R30is selected from ═O and ═S; W is —C(═O)—, —S(═O)—, or —S(O)2—; or W may be —CH2— if X is —C(═O)—; X is selected from —CH2—, —N(R4)—, and —O—, except that when W is —CH2—, X is —C(═O)—; Y is a bond or —C(R40)(R45)—; Q is a linker; Z is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocyclyl; and X1, X2, X3, X4, X5, X6, X7, X8, X9, X10and X11are selected such a tricyclic heteroaryl ring system is formed as further defined in the specification.
REFERENCES:
patent: 3835139 (1974-09-01), Pfister et al.
patent: 4250182 (1981-02-01), Gorvin
patent: 4374984 (1983-02-01), Eichler et al.
patent: 4686234 (1987-08-01), Nelson et al.
patent: 4725622 (1988-02-01), Nelson et al.
patent: 4727069 (1988-02-01), Nelson et al.
patent: 4753935 (1988-06-01), Nelson et al.
patent: 4786637 (1988-11-01), Allison et al.
patent: 4808592 (1989-02-01), Nelson et al.
patent: 4861776 (1989-08-01), Nelson et al.
patent: 4868153 (1989-09-01), Allison et al.
patent: 4948793 (1990-08-01), Allison et al.
patent: 4952579 (1990-08-01), Nelson et al.
patent: 4959387 (1990-09-01), Nelson et al.
patent: 4992467 (1991-02-01), Allison et al.
patent: 5247083 (1993-09-01), Knox et al.
patent: 5380879 (1995-01-01), Sjogren
patent: 5444072 (1995-08-01), Patterson et al.
patent: 5665583 (1997-09-01), Collart et al.
patent: 5807876 (1998-09-01), Armistead et al.
patent: 2004/0053955 (2004-03-01), Iwanowicz et al.
patent: 1009576 (1977-05-01), None
patent: 1009660 (1977-05-01), None
patent: 2243997 (1973-03-01), None
patent: 0 054 812 (1982-06-01), None
patent: 1382259 (1975-01-01), None
patent: 63-305173 (1988-12-01), None
patent: 11-130767 (1999-05-01), None
patent: WO 94/01105 (1994-01-01), None
patent: WO 94/12184 (1994-06-01), None
patent: WO 97/40028 (1997-10-01), None
patent: WO 98/15546 (1998-04-01), None
patent: WO 98/40381 (1998-09-01), None
patent: WO 00/23415 (2000-04-01), None
patent: WO 00/23416 (2000-04-01), None
patent: WO 03/059269 (2003-07-01), None
Chen et al. (J. Med. Chem. 1994, 37, 593-597).
Stewart, G. et al., Aust. J. Chem., vol. 37, pp. 1939-1950 (1984).
Chemical Abstracts, vol. 123, No. 3 (1995), abstract No. 32927 g.
SciFinder Acridones Listing of Abstracts.
Canelos, P.A. et al., Abstract 486: “Rolipram, a Type 4 Phosphodiesterase (PDE) Inhibitor, Promotes Induction of Neoantigen Tolerance in Murine T Cells” (593), J. Allergy Clin. Immunol. vol. 107, No. 2, p. S147.
Carr, S.F. et al., “Characterization of Human Type I and Type II IMP Dehydrogenases”, The Journal of Biological Chemistry, vol. 268, No. 36, pp. 27286-27290 (1993).
Collart, F.R. et al., “Cloning and Sequence Analysis of the Human and Chinese Hamster Inosine-5′-monophosphate Dehydrogenase cDNAs”, The Journal of Biological Chemistry, vol. 263, No. 3, pp. 15769-15772 (1988).
Jackson, R.C. et al., “IMP dehydrogenase, an enzyme linked with proliferation and malignancy”, Nature, vol. 256, pp. 331-333 (1975).
Konno, Y. et al., “Expression of Human IMP Dehydrogenase Types I and II inEscherichia coliand Distribution in Human Normal Lymphocytes and Leukemic Cell Lines”, The Journal of Biological Chemistry, vol. 266, No. 1, pp. 506-509 (1991).
Natsumeda, Y. et al., “Two Distinct cDNAs for Human IMP Dehydrogenase”, The Journal of Biological Chemistry, vol. 265, No. 9, pp. 5292-5295 (1990).
Chen Ping
Dhar T.G. Murali
Gu Henry
Iwanowicz Edwin J.
Watterson Scott H.
Berch Mark L
Bogie Terence J.
Bristol--Myers Squibb Company
Davis Stephen B.
Habte Kahsay
LandOfFree
Heterocyclic acridone inhibitors of IMPDH enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic acridone inhibitors of IMPDH enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic acridone inhibitors of IMPDH enzyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3381200